Year: 2009
Type: dissertation
Abstract: Esophageal cancer (EC) ranks among the ten most frequent cancers worldwide.Mortality rates associated with EC are very similar to the incidence rates due to the relatively late stage of diagnosis and the poor efficacy of treatment.The aim of this study was to enhance our insights of putative transcriptional circuitry of EC genes, thereby potentially positively impacting our knowledge of therapeutic targets, providing indications as to more appropriate lines of treatment, and additionally allowing for the determination of putative candidate diagnostic markers for the early stage detection of EC.This thesis reports on the development of a novel comprehensive database (Dragon Database of Genes Implicated in Esophageal Cancer, DDEC) as an integrated knowledge database aimed at representing a gateway to esophageal cancer related data.More importantly, it illustrates how the biocurated genes in the database may represent a reliable starting point for divulging transcriptional regulation, diagnostic markers and the biology related to esophageal cancer. IVDDEC contains known and novel information for 529 differentially expressed EC genes compiled using scientific publications from PubMed and is freely accessible for academic and non-profit users at http://apps.sanbi.ac.za/ddec/.The novel information provided to users of the DDEC is the lists of putative transcription factors that potentially control the 529 manually curated genes.The value of the information accessible through the database was further refined by providing precompiled text-mined and data-mined reports about each of these genes to allow for easy exploration of information about associations of EC-implicated genes with other human genes and proteins, metabolites and enzymes, toxins, chemicals with pharmacological effects, disease concepts and human anatomy.This feature has the capacity to display potential associations that are rarely reported and thus difficult to identify, and it enables the inspection of potentially new 'association hypotheses' generated based on the precompiled reports.This study further illustrates how the biocurated esophageal squamous cell carcinoma (ESCC) genes in the database may represent a reliable starting point for exploring beyond current knowledge of the transcriptional circuitry of estrogen related hormone therapy.The genes were used to develop a method that identified 44 combinations of transcription factors (TFs) that characterize the promoter sequence of estrogen responsive genes implicated in ESCC.These significantly over-represented combinations of TFs were then used to increase confidence in the 47 novel putative estrogen response genes that may be related to ESCC too.Coincidently, two of the novel putative estrogen response genes were verified by current (2009), experimental publications. VThe biocurated ESCC genes in the database were additionally used to expand on the current knowledge of the transcriptional circuitry of ESCC.The significantly over-represented transcription factors binding sites (TFBSs) were associated with the TFs that potentially bind at these sites.Since the TFs are known to regulate the gene expression, TFs were ranked and the top 10% of most regulating TFs; including, paired box 5 (PAX5), transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) (TFAP2A), Zic family member 2 (odd-paired homolog, Drosophila) (ZIC2), cAMP responsive element binding protein 1 (CREB1), E2F transcription factor 1 (E2F1), transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma) (TFAP2C), transcription factor Dp-1 (TFDP1), E2F transcription factor 3 (E2F3) and E2F transcription factor 4, p107/p130-binding (E2F4), were identified as the putative master regulators for ESCC.Additionally, the TFBSs that bind these master regulators were assessed for overlapping single nucleotide polymorphisms (SNPs) that may account for the deregulated expression of the genes under the control of these master regulators.Moreover, SNPs overlapping these TFBSs increase probability that such an altered TFBS and/or the associated TFs may be candidate biomarkers for ESCC.This research establishes the value of the developed DDEC database to the EC research community and reports on combinations of TFs and estrogen responsive genes that possibly play a role in the underlying mechanisms of gene expression affected by estrogen treatment.Additionally, the method developed for determining the combination of TFs that characterize the hormone responsive genes could be applicable to other hormone responsive cancers.Also, the identification of the ESCC master regulators as candidate diagnostic markers, may enhance our VI knowledge of the transcriptional circuitry that may positively impact our knowledge of therapeutic targets and side-effects associated with the implemented therapy, and should provide indications as to the most appropriate line of treatment.
Author: Magbubah Essack
Institution: University of the Western Cape
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: National Research Foundation
OpenAlex ID: W2285579229
